跳至主要内容
临床试验/NCT03384342
NCT03384342Unknown不适用

Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo

The Catholic University of Korea2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年11月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Recurrence of vitiligo

研究概览

简要总结

Although vitiligo is difficult to cure, recurrences are frequent after treatment, and many patients suffer from concerns about recurrence as well as disease. Psoriasis, another indication for ultraviolet radiation treatment, has been established that it can safely and effectively reduce the recurrence of psoriasis through monthly maintenance therapy.

The aim of this study was to evaluate the efficacy of Narrow-band UV-B therapy for the prevention of relapse in vitiligo.

详细描述

For a total period of 12 months, perform Narrow-band UV-B treatment once a month. Check for signs of enlarged vitiligo lesions at 3-month intervals for a total period of 12 months.

An independent evaluator will obtain the score of vitiligo area (Vitiligo Extent Score) from comparing clinical photographs of before registration and after the clinical trial, and judge whether vitiligo is recurred. This study is a randomized controlled trial, and the investigators plan to compare the recurrence rates of the experimental and control groups using the Chi-squared test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with age of 19 years or older
  • Patients of generalized vitiligo with lesions on the trunk
  • Patients who had treated with Narrow-band UV-B therapy previously and achieved more than 75% lesion improvement
  • Patients who voluntarily agreed to participate in the study

排除标准

  • Patients under the age of 19
  • Patients with localized vitiligo and segmental vitiligo
  • Patients who are in a state of physical or mental impairment to perform treatment or pregnant
  • Patients with spreading of vitiligo lesions
  • Patients who do not want to do thie study or who refuse to write a consent form
  • Any other person deemed unsuitable for the examination at the discretion of the examiner

研究组 & 干预措施

Experimental group

Experimental
  • For a total period of 12 months, perform Narrow-band UV-B therapy treatment once a month.
  • At this time, the dose of Narrow-band UV-B therapy therapy is based on the 50% of the maximum dose that the patient received for the treatment.

干预措施: Narrow-band UV-B therapy (Device)

Control group

No Intervention
  • Check for signs of enlarged vitiligo lesions at 3-month intervals for a total period of 12 months.
  • If recurrence of vitiligo is observed during the follow-up period, visit the clinic and check for recurrence.

结局指标

主要结局

Recurrence of vitiligo

时间窗: change from baseline area score at 12 months

Clinical photographs taken before and 12 months after the completion of the study. The photographs will be used to measure the area of vitiligo lesion, and the investigators will compare the area score and judge whether or not there is a recurrence.

次要结局

  • The assessment of patient satisfaction(at baseline and at 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jung Min Bae

Assistant Professor

The Catholic University of Korea

研究点 (2)

Loading locations...

相似试验